搡老女人多毛老妇女中国,日韩亚洲欧美中文高清在线,人妻少妇一区二区三区,色妞色综合久久夜夜,日本熟妇xxxx

Your Good Partner in Biology Research

重組蛋白

產(chǎn)品名稱 貨號 規(guī)格
Recombinant Lawsonia intracellularis Ribonuclease Y (rny), partial CSB-YP631945LAAL
CSB-EP631945LAAL
CSB-BP631945LAAL
CSB-MP631945LAAL
CSB-EP631945LAAL-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Lawsonia intracellularis ATP-dependent protease subunit HslV (hslV) CSB-YP631946LAAL
CSB-EP631946LAAL
CSB-BP631946LAAL
CSB-MP631946LAAL
CSB-EP631946LAAL-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Lawsonia intracellularis UDP-3-O-[3-hydroxymyristoyl] N-acetylglucosamine deacetylase (lpxC) CSB-YP631947LAAL
CSB-EP631947LAAL
CSB-BP631947LAAL
CSB-MP631947LAAL
CSB-EP631947LAAL-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Lawsonia intracellularis 30S ribosomal protein S9 (rpsI) CSB-YP631948LAAL
CSB-EP631948LAAL
CSB-BP631948LAAL
CSB-MP631948LAAL
CSB-EP631948LAAL-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Lawsonia intracellularis 5-methylthioadenosine/S-adenosylhomocysteine deaminase (mtaD) CSB-YP631949LAAL
CSB-EP631949LAAL
CSB-BP631949LAAL
CSB-MP631949LAAL
CSB-EP631949LAAL-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Lawsonia intracellularis ATP-dependent dethiobiotin synthetase BioD (bioD) CSB-YP631950LAAL
CSB-EP631950LAAL
CSB-BP631950LAAL
CSB-MP631950LAAL
CSB-EP631950LAAL-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Lawsonia intracellularis 1-deoxy-D-xylulose 5-phosphate reductoisomerase (dxr) CSB-YP631951LAAL
CSB-EP631951LAAL
CSB-BP631951LAAL
CSB-MP631951LAAL
CSB-EP631951LAAL-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Lawsonia intracellularis 50S ribosomal protein L9 (rplI) CSB-YP631952LAAL
CSB-EP631952LAAL
CSB-BP631952LAAL
CSB-MP631952LAAL
CSB-EP631952LAAL-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Lawsonia intracellularis Guanylate kinase (gmk) CSB-YP631953LAAL
CSB-EP631953LAAL
CSB-BP631953LAAL
CSB-MP631953LAAL
CSB-EP631953LAAL-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Lawsonia intracellularis Ribosomal RNA large subunit methyltransferase E (rlmE) CSB-YP631954LAAL
CSB-EP631954LAAL
CSB-BP631954LAAL
CSB-MP631954LAAL
CSB-EP631954LAAL-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Lawsonia intracellularis SsrA-binding protein (smpB) CSB-YP631955LAAL
CSB-EP631955LAAL
CSB-BP631955LAAL
CSB-MP631955LAAL
CSB-EP631955LAAL-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Lawsonia intracellularis Adenylosuccinate synthetase (purA) CSB-YP631956LAAL
CSB-EP631956LAAL
CSB-BP631956LAAL
CSB-MP631956LAAL
CSB-EP631956LAAL-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Lawsonia intracellularis GTPase Der (der) CSB-YP631957LAAL
CSB-EP631957LAAL
CSB-BP631957LAAL
CSB-MP631957LAAL
CSB-EP631957LAAL-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Danio rerio mRNA cap guanine-N7 methyltransferase (rnmt) CSB-YP631958DIL
CSB-EP631958DIL
CSB-BP631958DIL
CSB-MP631958DIL
CSB-EP631958DIL-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Schizosaccharomyces pombe UPF0661 TPR repeat-containing protein C16D10.01c (SPBC16D10.01c) CSB-YP631959SXV
CSB-EP631959SXV
CSB-BP631959SXV
CSB-MP631959SXV
CSB-EP631959SXV-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Schizosaccharomyces pombe Kinesin-like motor protein C15D4.01c (SPBC15D4.01c, SPBC2D10.21c), partial CSB-YP631960SXV
CSB-EP631960SXV
CSB-BP631960SXV
CSB-MP631960SXV
CSB-EP631960SXV-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Schizosaccharomyces pombe Uncharacterized oxidoreductase C16H5.14c (SPBC16H5.14c, SPBC21H7.08), partial CSB-YP631961SXV1
CSB-EP631961SXV1
CSB-BP631961SXV1
CSB-MP631961SXV1
CSB-EP631961SXV1-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Dactylopsila trivirgata NADH-ubiquinone oxidoreductase chain 4L (MT-ND4L), partial CSB-YP631962DAAO1
CSB-EP631962DAAO1
CSB-BP631962DAAO1
CSB-MP631962DAAO1
CSB-EP631962DAAO1-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Lake Victoria marburgvirus RNA-directed RNA polymerase L (L), partial CSB-YP631963LAAT
CSB-EP631963LAAT
CSB-BP631963LAAT
CSB-MP631963LAAT
CSB-EP631963LAAT-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Lake Victoria marburgvirus Polymerase cofactor VP35 (VP35) CSB-YP631964LAAQ
CSB-EP631964LAAQ
CSB-BP631964LAAQ
CSB-MP631964LAAQ
CSB-EP631964LAAQ-B
20μg/100μg/1mg(1mg*1 or 500ug*2)

有用資源

什么是重組蛋白?

重組蛋白是一種可操縱的蛋白質(zhì)形式,可以通過多種方式產(chǎn)生大量蛋白質(zhì)、修改基因序列和制造有用的商業(yè)產(chǎn)品。重組蛋白的技術(shù)資源在重組蛋白的開發(fā)過程中,除了表達系統(tǒng)之外,還面臨著一系列令人困惑的選擇,如表達載體的選擇、表達蛋白的長度(全長或部分)、是否帶標簽等。在生產(chǎn)重組蛋白時,你必須做出很多決定。如果你選擇的明智,你將獲得高質(zhì)量的重組蛋白,后續(xù)的實驗更有可能成功。但是如果你做了錯誤的決定,你可能得不到你所需要的重組蛋白或者重組蛋白的質(zhì)量和純度不符合要求。在這里,來自CUSABIO的蛋白表達工程師根據(jù)他們開發(fā)重組蛋白的經(jīng)驗總結(jié)出了幾個有用的提示,可以幫助你做出明智的決策。

第一條:重組蛋白的生產(chǎn),在這篇文章中,我們旨在闡明重組蛋白的定義以及如何生產(chǎn)重組蛋白。

第二條:如何選擇合適的表達載體?

表達載體是一種DNA分子,它攜帶特定的基因進入宿主細胞,并利用細胞的蛋白質(zhì)合成機制來產(chǎn)生由該基因編碼的蛋白質(zhì)。表達載體可使外源基因在宿主細胞中高效表達,經(jīng)過多年的發(fā)展,表達載體已成為一種成熟而受歡迎的生物技術(shù)。在重組蛋白生產(chǎn)過程中是一種基本成分。正如標題所示,本文主要總結(jié)了幾個有用的技巧來選擇合適的表達載體。

第三條:如何表達具有生物活性的蛋白質(zhì)?

根據(jù)重組蛋白的不同應用,對其生物活性有不同的要求。但是我們?nèi)绾未_保蛋白質(zhì)的產(chǎn)生具有生物活性呢?本文將圍繞這個主題,并提供一些解決方案。除了以上文章,我們還收集了一些重組蛋白的常見問題。您可以單擊以下鏈接查看。http://www.pptc.cn/technology-91.html。此外,我們還為我們的客戶提供重組蛋白表達服務,您可以點擊這里獲取更多信息。注:如果您對CUSABIO的蛋白質(zhì)有任何疑問,涉及到蛋白質(zhì)的價格、交貨、質(zhì)量等,您可以點擊橙色按鈕為我們在線留言。

引用資料

Recombinant Severe acute respiratory syndrome coronavirus 2 RNA-dependent RNA polymerase(NSP12) cited in "SARS-CoV-2 hijacks cellular kinase CDK2 to promote viral RNA synthesis". Signal transduction and targeted therapy, 2023

Recombinant Mouse Mixed lineage kinase domain-like protein(Mlkl) cited in "OASL phase condensation induces amyloid-like fibrillation of RIPK3 to promote virus-induced necroptosis". Nature cell biology, 2023

Recombinant Mouse Proto-oncogene c-Fos(Fos) cited in "Dihydroartemisinin imposes positive and negative regulation on Treg and plasma cells via direct interaction and activation of c-Fos". Communications biology, 2023

Recombinant Human Keratin, type I cytoskeletal 18(KRT18) cited in "Calcitonin gene-related peptide ameliorates sepsis-induced intestinal injury by suppressing NLRP3 inflammasome activation". International immunopharmacology, 2023

Recombinant Human Protein Wnt-5a (WNT5A) cited in "ATBF1 is a potential diagnostic marker of histological grade and functions via WNT5A in breast cancer". BMC Cancer, 2022

Read More >>